Skip to content
Recall Observatory FDA recall evidence

Drug product

TOBREX 0.3% 3.5GM OPTH; NDC/UPC 65064435; RX; OINTMENT

D-0533-2021

March 15, 2021

Class II

Product summary

Firm
Cardinal Health Inc.
Event
Event 87512
Status
Terminated
Classification
Class II
Quantity
28 tubes
Official record key
drug-enforcement:D-0533-2021

Official wording

Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Code information: 20B14E

Distribution pattern: FL, GA, SC

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations